Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2026
Tetracyclic triterpenes from Chios Mastic Gum act as TGR5 and RORγ modulators.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Perhal Alexander F, Bertaina Lorenza, González Jorge Enrique Hernández, Chen Ya, Schwarz Patrik F, Stamou Panagiota, Riffelsberger Katharina, Resetar Mirta, Halabalaki Maria, Kirchmair Johannes, Kostakis Ioannis K, Dirsch Verena M
Аннотация
BACKGROUND: Chios mastic gum (CMG) is a natural resin from Pistacia lentiscus L. var. Chia (Anacardiaceae). It contains high concentrations of triterpenoids, with 24Z-masticadienonic acid (24Z-MNA) and 24Z-isomasticadienonic acid (24Z-IMNA) being the predominant compounds. CMG has been reported to possess anti-inflammatory activity in vitro; however, the molecular targets remain unknown.
PURPOSE: Due to the structural similarity of tetracyclic CMG triterpenoids to bile acids, we investigated whether CMG constituents modulate bile acid-regulated receptors.
METHODS: Receptor activities and in vitro anti-inflammatory effects of CMG triterpenoids were assessed using cell-based assays and computational modeling.
RESULTS: We show that 24Z-IMNA acts as both a potent TGR5 agonist (EC50 = 1.7 µM) and an RORγ inverse agonist (IC50 = 329 nM), whereas 24Z-MNA shows modest activity on both receptors in luciferase reporter gene assays. The semi-synthetic isomer 24E-IMNA acted as a TGR5 agonist (EC50 = 2.2 µM) but lacked RORγ activity. TGR5 agonistic activities were confirmed in cAMP accumulation assays. 24Z-MNA, 24Z-IMNA and 24E-IMNA inhibited NF-κB transactivation TGR5-dependently and reduced NO production and Il1b mRNA expression in LPS-stimulated J774A.1 macrophages. The identified RORγ inverse agonist, 24Z-IMNA, showed concentration-dependent reductions in RORγ target gene expression (Il17a, Il17f and Il23r) by RT-qPCR. Computational modeling, including molecular docking, molecular dynamics (MD) simulations and free energy calculations, suggests plausible binding modes of those three compounds on TGR5 and RORγ, providing a structural basis for the observed activities.
CONCLUSION: Taken together, this study shows that CMG triterpenoids target TGR5 and RORγ, potentially contributing to their reported anti-inflammatory activities.
PURPOSE: Due to the structural similarity of tetracyclic CMG triterpenoids to bile acids, we investigated whether CMG constituents modulate bile acid-regulated receptors.
METHODS: Receptor activities and in vitro anti-inflammatory effects of CMG triterpenoids were assessed using cell-based assays and computational modeling.
RESULTS: We show that 24Z-IMNA acts as both a potent TGR5 agonist (EC50 = 1.7 µM) and an RORγ inverse agonist (IC50 = 329 nM), whereas 24Z-MNA shows modest activity on both receptors in luciferase reporter gene assays. The semi-synthetic isomer 24E-IMNA acted as a TGR5 agonist (EC50 = 2.2 µM) but lacked RORγ activity. TGR5 agonistic activities were confirmed in cAMP accumulation assays. 24Z-MNA, 24Z-IMNA and 24E-IMNA inhibited NF-κB transactivation TGR5-dependently and reduced NO production and Il1b mRNA expression in LPS-stimulated J774A.1 macrophages. The identified RORγ inverse agonist, 24Z-IMNA, showed concentration-dependent reductions in RORγ target gene expression (Il17a, Il17f and Il23r) by RT-qPCR. Computational modeling, including molecular docking, molecular dynamics (MD) simulations and free energy calculations, suggests plausible binding modes of those three compounds on TGR5 and RORγ, providing a structural basis for the observed activities.
CONCLUSION: Taken together, this study shows that CMG triterpenoids target TGR5 and RORγ, potentially contributing to their reported anti-inflammatory activities.